Speaker Profile
Biography
Isma is passionate about patient involvement in the Research & Development of innovative medicines, the life-cycle management of marketed products and is working extensively with various stakeholders to accelerate access to medicines. Prior to her current role, Isma was responsible for advancing Amgen’s expertise and leadership in Global Patient Safety & Labeling. With over 20 years of pharmaceutical industry experience, she has held various roles with increasing level of responsibility in different organizations. Prior to joining Amgen, she served as Vice President and Head of Safety Surveillance and Risk Management at Sanofi Genzyme and Executive Vice President with Pfizer Consumer Health Care. She has also worked in Clinical Development, Medical Affairs and Executive Management at Wyeth Pharmaceuticals and Eli Lilly France. Isma earned her MBA at the Massachusetts Institute of Technology, Masters in Bioethics from the U Pennsylvania and her medical degree in Psychiatry from Faculte de Medecine d’Alger.
Session Abstract – PMWC 2022 Silicon Valley
Today we see major gaps in oncology care delivery when it comes to transferring innovation from scientific discovery into clinical practice. Together with experienced industry professionals we will discuss persisting gaps along the oncology patient journey and how they can be addressed by making use of emerging trends.